Ccr5 Δ32 - Genetic Mutations

Relevant Publications

Investigating the Potential Impact of CCR5-Δ32 Variant on COVID-19 Outcome: A Case-Control Study in Iranian Population.

Issue Release: 2024

The CRISPR-Cas9 induced CCR5 Δ32 mutation as a potent gene therapy methodology for resistance to HIV-1 variant: a review.

Issue Release: 2024

Gaining momentum: stem cell therapies for HIV cure.

Issue Release: 2024

Exploring the Association of Biochemical Characterization and Genetic Determinants of TNF-α, CXCR2, and CCR5 Delta 32 Mutation with Predisposition to Polycystic Ovary Syndrome.

Issue Release: 2024

A Randomized Placebo-Controlled Trial of Leronlimab in Mild-To-Moderate COVID-19.

Issue Release: 2024

CRISPR/Cas9 genome editing of CCR5 combined with C46 HIV-1 fusion inhibitor for cellular resistant to R5 and X4 tropic HIV-1.

Issue Release: 2024

CCR5 Δ32 and CTLA-4 +49 A/G Gene Polymorphisms and Interferon-β Treatment Response in Croatian and Slovenian Multiple Sclerosis Patients.

Issue Release: 2024

Association between chemokine genes polymorphisms and susceptibility to Parkinson\'s disease: a meta-analysis and systematic review.

Issue Release: 2024

Narrowing the Relationship between Human CCR5 Gene Polymorphisms and Chagas Disease: Systematic Review and Meta-Analysis.

Issue Release: 2023

CCR5 deficiency: Decreased neuronal resilience to oxidative stress and increased risk of vascular dementia.

Issue Release: 2023

CCR5 promoter region polymorphisms in systemic lupus erythematosus.

Issue Release: 2023

Dual effect of C-C motif chemokine receptor 5 on ischemic stroke: More harm than benefit?

Issue Release: 2023

Honduras HIV cohort: HLA class I and CCR5-Δ32 profiles and their associations with HIV disease outcome.

Issue Release: 2023

Autopsy Study Defines Composition and Dynamics of the HIV-1 Reservoir after Allogeneic Hematopoietic Stem Cell Transplantation with CCR5Δ32/Δ32 Donor Cells.

Issue Release: 2022

Factors Influencing Immune Restoration in People Living with HIV/AIDS.

Issue Release: 2022

Biallelic, Selectable, Knock-in Targeting of CCR5 CRISPR-Cas9 Mediated Homology Directed Repair Inhibits HIV-1 Replication.

Issue Release: 2022

The CCR5 Gene Edited CD34CD90 Hematopoietic Stem Cell Population Serves as an Optimal Graft Source for HIV Gene Therapy.

Issue Release: 2022

CCR5 as a Coreceptor for Human Immunodeficiency Virus and Simian Immunodeficiency Viruses: A Prototypic Love-Hate Affair.

Issue Release: 2022

CCR5-Δ32 polymorphism - a possible protective factor from gait impairment among post-stroke patients.

Issue Release: 2022

CCR5-Δ32 gene variant frequency in the Nigerian and Zimbabwean populations living in North Cyprus.

Issue Release: 2022

How is Sickle Cell Anemia Inherited?

What is the Future of Genetic Approaches in Cancer Treatment?

What is Cellular Heterogeneity?

Do Genetic Mutations Always Have Positive Effects?

Are There Any Specific Genetic Mutations That Predict Response to Immunotherapy?

Can the body repair PAH-induced DNA damage?

Are CNVs Inherited?

Can Mutations Be Prevented or Controlled?

What Is the Future of PARP Inhibitors?

What is the Future of Genetic Mutations in Agriculture?

Partnered Content Networks

Relevant Topics